Quinazoline derivatives as antiproliferative agents

Quinazoline derivatives as antiproliferative agents

1a1b23 The invention concerns quinazoline derivatives of Formula (I), wherein each of R, R, R, Rand a have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Barlaam, Bernard Christophe, Hennequin, Laurent Francois Andre, Halsall, Christopher Thomas
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Barlaam, Bernard Christophe
Hennequin, Laurent Francois Andre
Halsall, Christopher Thomas
description 1a1b23 The invention concerns quinazoline derivatives of Formula (I), wherein each of R, R, R, Rand a have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07838530</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07838530</sourcerecordid><originalsourceid>FETCH-uspatents_grants_078385303</originalsourceid><addsrcrecordid>eNrjZDAOLM3MS6zKz8nMS1VISS3KLEssySxLLVZIBKK8ksyCIqBUWmoRWFQhMT01r6SYh4E1LTGnOJUXSnMzKLi5hjh76JYWFySWgFTEpxclgigDcwtjC1NjA2MilAAAN1kuPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Quinazoline derivatives as antiproliferative agents</title><source>USPTO Issued Patents</source><creator>Barlaam, Bernard Christophe ; Hennequin, Laurent Francois Andre ; Halsall, Christopher Thomas</creator><creatorcontrib>Barlaam, Bernard Christophe ; Hennequin, Laurent Francois Andre ; Halsall, Christopher Thomas ; AstraZeneca AB</creatorcontrib><description>1a1b23 The invention concerns quinazoline derivatives of Formula (I), wherein each of R, R, R, Rand a have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7838530$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7838530$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Barlaam, Bernard Christophe</creatorcontrib><creatorcontrib>Hennequin, Laurent Francois Andre</creatorcontrib><creatorcontrib>Halsall, Christopher Thomas</creatorcontrib><creatorcontrib>AstraZeneca AB</creatorcontrib><title>Quinazoline derivatives as antiproliferative agents</title><description>1a1b23 The invention concerns quinazoline derivatives of Formula (I), wherein each of R, R, R, Rand a have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDAOLM3MS6zKz8nMS1VISS3KLEssySxLLVZIBKK8ksyCIqBUWmoRWFQhMT01r6SYh4E1LTGnOJUXSnMzKLi5hjh76JYWFySWgFTEpxclgigDcwtjC1NjA2MilAAAN1kuPw</recordid><startdate>20101123</startdate><enddate>20101123</enddate><creator>Barlaam, Bernard Christophe</creator><creator>Hennequin, Laurent Francois Andre</creator><creator>Halsall, Christopher Thomas</creator><scope>EFH</scope></search><sort><creationdate>20101123</creationdate><title>Quinazoline derivatives as antiproliferative agents</title><author>Barlaam, Bernard Christophe ; Hennequin, Laurent Francois Andre ; Halsall, Christopher Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_078385303</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Barlaam, Bernard Christophe</creatorcontrib><creatorcontrib>Hennequin, Laurent Francois Andre</creatorcontrib><creatorcontrib>Halsall, Christopher Thomas</creatorcontrib><creatorcontrib>AstraZeneca AB</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Barlaam, Bernard Christophe</au><au>Hennequin, Laurent Francois Andre</au><au>Halsall, Christopher Thomas</au><aucorp>AstraZeneca AB</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Quinazoline derivatives as antiproliferative agents</title><date>2010-11-23</date><risdate>2010</risdate><abstract>1a1b23 The invention concerns quinazoline derivatives of Formula (I), wherein each of R, R, R, Rand a have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07838530
source USPTO Issued Patents
title Quinazoline derivatives as antiproliferative agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A35%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Barlaam,%20Bernard%20Christophe&rft.aucorp=AstraZeneca%20AB&rft.date=2010-11-23&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07838530%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true